www.varchev.com

7 Best Dividend Stocks to Buy for 2017

Rating:

12345
Loading...

1. AbbVie - Dividend yield: 4%
The pharmaceutical sector is heaving a sigh of relief. There’s little wonder why. Hillary Clinton said her administration would clamp down on rising drug prices. That means a number of pharma stocks with strong yields now look even better for 2017. AbbVie Inc. (ABBV) stock is shooting higher in response to the election. The dividend only pads that lead. Slow-but-steady growth is a basic part of the equation.
AbbVie successfully completed the acquisition of Stemcentrx in June, which bolsters its portfolio of oncology treatments. The ability to make similar moves going forward is now less certain.Be that as it may, AbbVie looks like a tremendous dividend name. It’s only been around since 2013, and yet its payout has grown by more than 40% in that short time.

2. Chevron - Dividend yield: 4%
This one is a bit more complicated. Chevron Corporation (CVX) and other energy names will benefit from a pro-fossil fuel policy. Recession or trade wars, however, will sap demand for oil.For now, though, oil prices appear to have stabilized. As an integrated energy major, Chevron’s downstream business offers a bit of a hedge against weakness in crude oil anyway.Oil prices are cyclical — even if the cycles can take a painfully long time to turn. And a dividend yield of more than 4% is mighty attractive in an ultra-low interest rate environment.Perhaps best of all, patient investors — that is, buy-and-hold types — can look forward to a steady drumbeat of payout hikes. Through thick-and-thin energy markets, CVX has raised its dividend for 30 consecutive years.

3. General Electric - Dividend yield: 3%
As long as international trade policy doesn’t go off the rails, General Electric Company‘s (GE) long-term strategy sounds too good to ignore. But investors will need to remain patient. General Electric’s earnings underscore the difficulty of shedding the firm’s financial businesses at a time when the oil and gas industry is depressed. GE is putting a lot of distance between it and the oil and gas business by merging it with Baker Hughes Incorporated (BHI). That helps mitigate some of the macroeconomic risk from the industry.

4. Merck - Dividend yield: 2.8%
Merck & Co., Inc. (MRK) was an attractive dividend name even before the latest developments. Indeed, it is having an outstanding year, with gains more than 20%. If there’s a downside to that, price appreciation has lowered the yield on the dividend to right around the 3% mark. Take price appreciation, throw in the dividend and MRK — a component of the Dow Jones Industrial Average — looks good for better-than-average total returns.

5. Pfizer - Dividend yield: 3.6%
Pfizer Inc. (PFE) is another pharma giant that also happens to be a Dow component. Shares weren’t having a very good year — up until Wednesday. Now, sentiment couldn’t be high. n addition to the outsized yield, PFE has fundamental reasons to become a part of your equity income portfolio. It has a strong pipeline with 94 clinical studies under way. Furthermore, a buyout bender — which have already been concluded — promises long-term price appreciation to go along with a steady dividend stream. In this year alone, PFE bought Medivation Inc. for $14 billion and Anacor Pharmaceuticals Inc. for $5.2 billion.

6. Wells Fargo - Dividend yield: 3%
Wells Fargo & Co. (WFC) was a buy even before the outcome of the election. No, it might not be the most popular name after its phony accounts scandal, but that actually works in a value investor’s favor. It’s still a quality business with a quality stock. Bank crises eventually blow over. This, too, shall pass. Shares in WFC went to $46 from $51 on the news. That has the dividend up to a very attractive level.

7. Verizon - Dividend yield: 4.9%
The telecommunications sector is a haven for equity income investors. You can’t begin any discussion of dividend stocks without considering names like Verizon Communications Inc. (VZ). As much as traditional telecommunications is a poky business, VZ is making some interesting moves. Most notably, it struck a deal to acquire the core properties of Yahoo! Inc. (YHOO) to drive new revenue streams and position itself for the future.


 Varchev Traders
RECCOMEND WAS THIS POST USEFUL FOR YOU?
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance

London


25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256

Universal numbers

World Financial Markets - 0700 17 600    Varchev Exchange - 0700 115 44

Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.

Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006

The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.


Disclaimer:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

chat with dealer
chat with dealer
Cookies policy